Sun Pharma, Dr Reddy's, Zydus, Mankind among first movers as India's semaglutide market opens post patent expiry
Published on: March 19, 2026, 11:25 a.m. | Source: Business Today
As Novo Nordisk’s patent expires on March 20, Sun Pharma, Dr Reddy’s, Zydus and Mankind enter the market after months of preparation, setting up a race for early share in one of the world’s most in-demand drug categories.
